Flerie AB (FRA:1NP1) Cyclically Adjusted Book per Share: €5.68 (As of Jun. 2026)


FRA:1NP1 Flerie AB FRA:1NP1
37 GF Score
Price €1.81
! 2 Warning Signs
View Full Analysis

What is Flerie AB Cyclically Adjusted Book per Share?

Flerie AB FRA:1NP1 37 Cyclically Adjusted Book per Share is €5.68 as of Jun. 2026. GuruFocus rates FRA:1NP1 with a GF Score™ of 37/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Flerie AB's adjusted book value per share for the three months ended in Jun. 2026 was €3.571. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.68 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Flerie AB's average Cyclically Adjusted Book Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-12), Flerie AB's current stock price is €1.81. Flerie AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €5.68. Flerie AB's Cyclically Adjusted PB Ratio of today is 0.32.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Flerie AB was 0.62. The lowest was 0.30. And the median was 0.51.


Flerie AB  (FRA:1NP1) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Flerie AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.81/5.68
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Flerie AB was 0.62. The lowest was 0.30. And the median was 0.51.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Flerie AB Cyclically Adjusted Book per Share Related Terms


Flerie AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Flerie AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Flerie AB Cyclically Adjusted Book per Share Chart

Flerie AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 6.18

Flerie AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.84 5.82 6.18 5.85 5.68

FRA:1NP1 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Flerie AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flerie AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Flerie AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Flerie AB's Cyclically Adjusted PB Ratio falls into.


FRA:1NP1
37GF Score
Flerie AB FRA:1NP1
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Flerie AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Flerie AB's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.571/132.7900*132.7900
=3.571

Current CPI (Jun. 2026) = 132.7900.

Flerie AB Quarterly Data

Book Value per Share CPI Adj_Book
201609 -2.782 101.138 -3.653
201612 9.826 102.022 12.789
201703 8.553 102.022 11.132
201706 7.546 102.752 9.752
201709 6.987 103.279 8.983
201712 5.767 103.793 7.378
201803 4.440 103.962 5.671
201806 3.062 104.875 3.877
201809 2.257 105.679 2.836
201812 2.995 105.912 3.755
201903 1.939 105.886 2.432
201906 1.122 106.742 1.396
201909 3.120 107.214 3.864
201912 3.755 107.766 4.627
202003 2.802 106.563 3.492
202006 2.358 107.498 2.913
202009 2.105 107.635 2.597
202012 1.792 108.296 2.197
202103 8.519 108.360 10.440
202106 7.872 108.928 9.596
202109 7.377 110.338 8.878
202112 6.942 112.486 8.195
202203 6.474 114.825 7.487
202206 6.093 118.384 6.834
202209 5.933 122.296 6.442
202212 4.990 126.365 5.244
202303 4.280 127.042 4.474
202306 5.382 129.407 5.523
202309 4.782 130.224 4.876
202312 52.361 131.912 52.710
202403 3.425 132.205 3.440
202406 4.348 132.716 4.350
202409 4.207 132.304 4.222
202412 4.091 132.987 4.085
202503 4.039 132.825 4.038
202506 4.402 133.699 4.372
202509 4.023 133.480 4.002
202512 3.506 133.390 3.490
202603 3.583 133.560 3.562
202606 3.571 132.790 3.571

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €5.68 mean?
Flerie AB (FRA:1NP1) has a Cyclically Adjusted Book per Share of €5.68 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Flerie AB and its competitors.
Is Flerie AB's Cyclically Adjusted Book per Share too high?
Flerie AB's current Cyclically Adjusted Book per Share is €5.68. Overall, Flerie AB has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Flerie AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Flerie AB's Cyclically Adjusted Book per Share of €5.68 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Flerie AB and its competitors. Flerie AB's current Cyclically Adjusted Book per Share is €5.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Flerie AB stock overvalued right now?
Flerie AB (FRA:1NP1) has a current Cyclically Adjusted Book per Share of €5.68. The current Cyclically Adjusted Book per Share is €5.68. Flerie AB's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Flerie AB (FRA:1NP1), the current Cyclically Adjusted Book per Share is €5.68 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Flerie AB Business Description

Other Exchanges FLERIE:Sweden1NP1:Germany
Address Skeppsbron 16, Stockholm, SWE, 111 30
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations. It operates in two segments The Product Development segment, and The Commercial Growth segment. The Product Development segment consists of early and mid-stage biotech and pharma companies advancing their products and technologies toward clinical proofof-concept and marketing approvals. The Commercial Growth segment consists of companies already selling products or services, showcasing their ability to generate increasing revenues ahead of reaching sustainable profitability.
37GF Score

Get the complete analysis for FRA:1NP1

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.81
Price